Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid

Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoidApproval in ...

Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained ...

Regeneron Pharmaceuticals, Inc.: Dupixent (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...
The Maravi Post

Malawi Parliament passes MK10.9 trillion 2026/27 Fiscal plan with key sectors priority

LILONGWE-(MaraviPost)-Malawi Parliament has approved the 2026/27 National Budget, authorising a total of MK10.978 trillion in government expenditure following weeks of detailed scrutiny, debate and ...
The Maravi Post

My Cape Town: Marc Lottering

Comedy legend Marc Lottering is no stranger to the spotlight, bringing laughter to households across Cape Town. With his signature funky Afro and infectious laugh, the Woodstock local is known for his ...